92 studies found for:    Open Studies | "Urinary Bladder, Overactive"
Show Display Options
Rank Status Study
21 Recruiting Effects and Safety of Liposome Encapsulated Botulinum Toxin A for Overactive Bladder Syndrome
Condition: Overactive Bladder
Interventions: Drug: Liposome encapsulated botulinum toxin A;   Drug: Normal saline instillation
22 Recruiting A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder
Conditions: Pharmacokinetics of Mirabegron;   Neurogenic Detrusor Overactivity;   Overactive Bladder
Intervention: Drug: Mirabegron
23 Recruiting Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome
Condition: Overactive Bladder
Interventions: Drug: Detrusitol 4mg QD and Oxybutynin ER 5mg QD;   Drug: Detrusitol 4mg QD
24 Unknown  A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder
Condition: Overactive Bladder Associated With HTLV-1
Interventions: Drug: Propantheline Bromide;   Drug: Placebo
25 Unknown  Cystoscopy Plus Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding
Conditions: Overactive Bladder Syndrome;   Voiding Dysfunction
Interventions: Procedure: Cystoscopy;   Procedure: Cystoscopy and urethral dilatation
26 Not yet recruiting Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)
Condition: Overactive Bladder (OAB)
Interventions: Drug: Mirabegron;   Drug: Placebo
27 Recruiting A Study to Evaluate Tolerability and Patient Preference Between Myrbetriq® and Detrol® LA in Subjects With Overactive Bladder (OAB)
Condition: Overactive Bladder (OAB)
Interventions: Drug: Myrbetriq;   Drug: Detrol LA
28 Recruiting An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder
Conditions: Urinary Incontinence;   Urinary Bladder, Overactive
Intervention: Biological: botulinum toxin Type A
29 Recruiting OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients
Conditions: Urinary Incontinence;   Urinary Bladder, Overactive
Intervention: Biological: OnabotulinumtoxinA
30 Recruiting Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea
Conditions: Urinary Incontinence;   Urinary Bladder, Overactive
Intervention: Biological: botulinum toxin Type A
31 Unknown  Validation of Instruments for Pragmatic Clinical Trials for Overactive Bladder
Condition: Overactive Bladder
Intervention: Drug: Toviaz
32 Recruiting Biowave Overactive Bladder Trial
Condition: Overactive Bladder
Intervention: Device: Biowave Treatment
33 Unknown  Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder
Condition: Overactive Bladder
Intervention: Behavioral: Health education intervention (HEI)
34 Not yet recruiting Educating Patients on Management of Overactive Bladder: Written Versus Verbal Instructions
Condition: Overactive Bladder
Intervention: Other: Written List
35 Recruiting Secondary Bilateral Sacral Nerve Stimulation in Overactive Bladder Patients
Condition: Bladder Hyperactivity
Intervention: Device: Device: INTERSTIM II
36 Unknown  Pilot Study: Is Overactive Bladder Caused by Subacute Urinary Tract Infections?
Condition: Overactive Bladder
Intervention:
37 Recruiting "The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"
Conditions: Overactive Bladder;   Caffeine;   Menopause
Interventions: Dietary Supplement: 400 mg of caffeine/day (Two 200mg pills/day);   Dietary Supplement: 200 mg of caffeine/day (One 200mg pill and one placebo pill);   Dietary Supplement: Two placebo pills/day
38 Recruiting Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome
Condition: Overactive Bladder
Interventions: Drug: BoNT-A (10 injection);   Drug: BoNT-A (20 injection);   Drug: BoNT-A (40 injection)
39 Unknown  Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction
Condition: Overactive Bladder
Intervention: Drug: Botox/Placebo
40 Recruiting Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women
Condition: Overactive Bladder
Interventions: Drug: Tolterodine tartrate extended release capsules + Placebo orally disintegrating tablets;   Drug: Tolterodine tartrate extended release capsules + Desmopressin orally disintegrating tablets

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years